Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000908834-25-000362
Filing Date
2025-11-24
Accepted
2025-11-24 19:25:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 45021
2 JOINT ACQUISITION STATEMENT jas.htm EX-1 12685
  Complete submission text file 0000908834-25-000362.txt   59746
Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132
Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

EIN.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025 (833) 694-2553
GRAIL, Inc. (Subject) CIK: 0001699031 (see all company filings)

EIN.: 863673636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94591 | Film No.: 251514691
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)